← Back to Search

Argon laser trabeculoplasty for Glaucoma

N/A
Waitlist Available
Led By Catherine M Birt, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two years
Awards & highlights

Summary

Laser trabeculoplasty is a routine treatment for glaucoma and can be performed with either argon (ALT) or selective Yag (SLT) lasers. The effectiveness of each has not been studied in patients under 60 years, which is younger than average for the procedure. The study hypothesis is that there will be no difference between the two laser types.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two years
This trial's timeline: 3 weeks for screening, Varies for treatment, and two years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intraocular pressure

Trial Design

2Treatment groups
Active Control
Group I: Argon laser trabeculoplastyActive Control1 Intervention
Patients received standard argon laser treatment
Group II: Selective laser trabeculoplastyActive Control1 Intervention
Patients received a standard selective laser treatment

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
671 Previous Clinical Trials
1,564,593 Total Patients Enrolled
4 Trials studying Glaucoma
304 Patients Enrolled for Glaucoma
Catherine M Birt, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top